Search by Drug Name or NDC

    NDC 67457-0359-59 Fluphenazine Decanoate 25 mg/mL Details

    Fluphenazine Decanoate 25 mg/mL

    Fluphenazine Decanoate is a INTRAMUSCULAR; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is FLUPHENAZINE DECANOATE.

    Product Information

    NDC 67457-0359
    Product ID 67457-359_cf242100-3073-4d9c-823c-5430a58e9c0e
    Associated GPIs 59200025302005
    GCN Sequence Number 003818
    GCN Sequence Number Description fluphenazine decanoate VIAL 25 MG/ML INJECTION
    HIC3 H2G
    HIC3 Description ANTIPSYCHOTICS,PHENOTHIAZINES
    GCN 14540
    HICL Sequence Number 001624
    HICL Sequence Number Description FLUPHENAZINE DECANOATE
    Brand/Generic Generic
    Proprietary Name Fluphenazine Decanoate
    Proprietary Name Suffix n/a
    Non-Proprietary Name FLUPHENAZINE DECANOATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; SUBCUTANEOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/mL
    Substance Name FLUPHENAZINE DECANOATE
    Labeler Name Mylan Institutional LLC
    Pharmaceutical Class Phenothiazine [EPC], Phenothiazines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075918
    Listing Certified Through 2024-12-31

    Package

    NDC 67457-0359-59 (67457035959)

    NDC Package Code 67457-359-59
    Billing NDC 67457035959
    Package 1 VIAL, MULTI-DOSE in 1 CARTON (67457-359-59) / 5 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2018-09-28
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 16.2184
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description FLUPHENAZINE DEC 125 MG/5 ML
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis